Bernard Ravina, Chief Medical Officer at Voyager Therapeutics, Inc. (VYGR), sold 2,451 shares at $18.38 ($45K) on 2018-04-10, disclosed to the SEC on 2018-04-12.
Scheduled sale ($45k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VYGR | SELL | 2018-01-12 | $119K | — | Filing → |
| VYGR | SELL | 2017-12-13 | $150K | — | Filing → |
| VYGR | SELL | 2017-11-13 | $146K | — | Filing → |